Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Anti-CD37 chimeric antigen receptor T cells are active against B- and T-cell lymphomas.

Scarfò I, Ormhøj M, Frigault MJ, Castano AP, Lorrey S, Bouffard AA, van Scoyk A, Rodig SJ, Shay AJ, Aster JC, Preffer FI, Weinstock DM, Maus MV.

Blood. 2018 Oct 4;132(14):1495-1506. doi: 10.1182/blood-2018-04-842708. Epub 2018 Aug 8. Erratum in: Blood. 2018 Dec 6;132(23):2527.

PMID:
30089630
2.

Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery.

Tang L, Zheng Y, Melo MB, Mabardi L, Castaño AP, Xie YQ, Li N, Kudchodkar SB, Wong HC, Jeng EK, Maus MV, Irvine DJ.

Nat Biotechnol. 2018 Sep;36(8):707-716. doi: 10.1038/nbt.4181. Epub 2018 Jul 9.

3.

Frontline Science: Targeted expression of a dominant-negative high mobility group A1 transgene improves outcome in sepsis.

Baron RM, Kwon MY, Castano AP, Ghanta S, Riascos-Bernal DF, Lopez-Guzman S, Macias AA, Ith B, Schissel SL, Lederer JA, Reeves R, Yet SF, Layne MD, Liu X, Perrella MA.

J Leukoc Biol. 2018 Oct;104(4):677-689. doi: 10.1002/JLB.4HI0817-333RR. Epub 2018 Jul 5.

PMID:
29975792
4.

CpG oligodeoxynucleotide as immune adjuvant enhances photodynamic therapy response in murine metastatic breast cancer.

Xia Y, Gupta GK, Castano AP, Mroz P, Avci P, Hamblin MR.

J Biophotonics. 2014 Nov;7(11-12):897-905. doi: 10.1002/jbio.201300072. Epub 2013 Aug 7.

5.

MicroRNA-21 promotes fibrosis of the kidney by silencing metabolic pathways.

Chau BN, Xin C, Hartner J, Ren S, Castano AP, Linn G, Li J, Tran PT, Kaimal V, Huang X, Chang AN, Li S, Kalra A, Grafals M, Portilla D, MacKenna DA, Orkin SH, Duffield JS.

Sci Transl Med. 2012 Feb 15;4(121):121ra18. doi: 10.1126/scitranslmed.3003205.

6.

The melanoma-associated transmembrane glycoprotein Gpnmb controls trafficking of cellular debris for degradation and is essential for tissue repair.

Li B, Castano AP, Hudson TE, Nowlin BT, Lin SL, Bonventre JV, Swanson KD, Duffield JS.

FASEB J. 2010 Dec;24(12):4767-81. doi: 10.1096/fj.10-154757. Epub 2010 Aug 13.

7.

Serum amyloid P inhibits fibrosis through Fc gamma R-dependent monocyte-macrophage regulation in vivo.

Castaño AP, Lin SL, Surowy T, Nowlin BT, Turlapati SA, Patel T, Singh A, Li S, Lupher ML Jr, Duffield JS.

Sci Transl Med. 2009 Nov 4;1(5):5ra13. doi: 10.1126/scitranslmed.3000111. Erratum in: Sci Transl Med. 2009 Nov 4;1(5):5ra13.

8.

Bone marrow Ly6Chigh monocytes are selectively recruited to injured kidney and differentiate into functionally distinct populations.

Lin SL, Castaño AP, Nowlin BT, Lupher ML Jr, Duffield JS.

J Immunol. 2009 Nov 15;183(10):6733-43. doi: 10.4049/jimmunol.0901473. Epub 2009 Oct 28.

9.

Chitosan acetate bandage as a topical antimicrobial dressing for infected burns.

Dai T, Tegos GP, Burkatovskaya M, Castano AP, Hamblin MR.

Antimicrob Agents Chemother. 2009 Feb;53(2):393-400. doi: 10.1128/AAC.00760-08. Epub 2008 Nov 17.

10.

Effect of chitosan acetate bandage on wound healing in infected and noninfected wounds in mice.

Burkatovskaya M, Castano AP, Demidova-Rice TN, Tegos GP, Hamblin MR.

Wound Repair Regen. 2008 May-Jun;16(3):425-31. doi: 10.1111/j.1524-475X.2008.00382.x.

11.

Photodynamic therapy plus low-dose cyclophosphamide generates antitumor immunity in a mouse model.

Castano AP, Mroz P, Wu MX, Hamblin MR.

Proc Natl Acad Sci U S A. 2008 Apr 8;105(14):5495-500. doi: 10.1073/pnas.0709256105. Epub 2008 Mar 31.

12.

Intravascular detection of inflamed atherosclerotic plaques using a fluorescent photosensitizer targeted to the scavenger receptor.

Tawakol A, Castano AP, Gad F, Zahra T, Bashian G, Migrino RQ, Ahmadi A, Stern J, Anatelli F, Chirico S, Shirazi A, Syed S, Fischman AJ, Muller JE, Hamblin MR.

Photochem Photobiol Sci. 2008 Jan;7(1):33-9. doi: 10.1039/b710746c. Epub 2007 Oct 29.

13.

Low-level laser therapy for zymosan-induced arthritis in rats: Importance of illumination time.

Castano AP, Dai T, Yaroslavsky I, Cohen R, Apruzzese WA, Smotrich MH, Hamblin MR.

Lasers Surg Med. 2007 Jul;39(6):543-50.

14.

Macrophage-targeted photosensitizer conjugate delivered by intratumoral injection.

Anatelli F, Mroz P, Liu Q, Yang C, Castano AP, Swietlik E, Hamblin MR.

Mol Pharm. 2006 Nov-Dec;3(6):654-64.

15.

Photodynamic therapy and anti-tumour immunity.

Castano AP, Mroz P, Hamblin MR.

Nat Rev Cancer. 2006 Jul;6(7):535-45. Review.

16.

Photosensitizer delivery to vulnerable atherosclerotic plaque: comparison of macrophage-targeted conjugate versus free chlorin(e6).

Tawakol A, Castano AP, Anatelli F, Bashian G, Stern J, Zahra T, Gad F, Chirico S, Ahmadi A, Fischman AJ, Muller JE, Hamblin MR.

J Biomed Opt. 2006 Mar-Apr;11(2):021008.

17.
18.

Mechanisms in photodynamic therapy: Part three-Photosensitizer pharmacokinetics, biodistribution, tumor localization and modes of tumor destruction.

Castano AP, Demidova TN, Hamblin MR.

Photodiagnosis Photodyn Ther. 2005 Jun;2(2):91-106. doi: 10.1016/S1572-1000(05)00060-8. Epub 2005 Aug 10.

19.

Mechanisms in photodynamic therapy: part two-cellular signaling, cell metabolism and modes of cell death.

Castano AP, Demidova TN, Hamblin MR.

Photodiagnosis Photodyn Ther. 2005 Mar;2(1):1-23. doi: 10.1016/S1572-1000(05)00030-X.

20.

Mechanisms in photodynamic therapy: part one-photosensitizers, photochemistry and cellular localization.

Castano AP, Demidova TN, Hamblin MR.

Photodiagnosis Photodyn Ther. 2004 Dec;1(4):279-93. doi: 10.1016/S1572-1000(05)00007-4.

Supplemental Content

Loading ...
Support Center